Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair

Chrisoula A. Toupadakis, Alice Wong, Damian C Genetos, Dai Jung Chung, Deepa Murugesh, Matthew J. Anderson, Gabriela G. Loots, Blaine A Christiansen, Amy Kapatkin, Clare E Yellowley-genetos

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Fracture healing involves rapid stem and progenitor cell migration, homing, and differentiation. SDF-1 (CXCL12) is considered a master regulator of CXCR4-positive stem and progenitor cell trafficking to sites of ischemic (hypoxic) injury and regulates their subsequent differentiation into mature reparative cells. In this study, we investigated the role of SDF-1/CXCR4 signaling in fracture healing where vascular disruption results in hypoxia and SDF-1 expression. Mice were injected with AMD3100, a CXCR4 antagonist, or vehicle twice daily until euthanasia with the intent to impair stem cell homing to the fracture site and/or their differentiation. Fracture healing was evaluated using micro-computed tomography, histology, quantitative PCR, and mechanical testing. AMD3100 administration resulted in a significantly reduced hyaline cartilage volume (day 14), callus volume (day 42) and mineralized bone volume (day 42) and reduced expression of genes associated with endochondral ossification including collagen Type 1 alpha 1, collagen Type 2 alpha 1, vascular endothelial growth factor, Annexin A5, nitric oxide synthase 2, and mechanistic target of rapamycin. Our data suggest that the SDF-1/CXCR4 signaling plays a central role in bone healing possibly by regulating the recruitment and/or differentiation of stem and progenitor cells.

Original languageEnglish (US)
Pages (from-to)1853-1859
Number of pages7
JournalJournal of Orthopaedic Research
Volume30
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Stem Cells
Fracture Healing
Hyaline Cartilage
Bone and Bones
Euthanasia
Collagen Type II
Annexin A5
Bony Callus
Sirolimus
Collagen Type I
JM 3100
Osteogenesis
Nitric Oxide Synthase
Vascular Endothelial Growth Factor A
Cell Movement
Blood Vessels
Cell Differentiation
Histology
Tomography
Gene Expression

Keywords

  • adult-derived stem cells
  • AMD3100
  • CXCR4
  • fracture
  • SDF-1

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. / Toupadakis, Chrisoula A.; Wong, Alice; Genetos, Damian C; Chung, Dai Jung; Murugesh, Deepa; Anderson, Matthew J.; Loots, Gabriela G.; Christiansen, Blaine A; Kapatkin, Amy; Yellowley-genetos, Clare E.

In: Journal of Orthopaedic Research, Vol. 30, No. 11, 11.2012, p. 1853-1859.

Research output: Contribution to journalArticle

Toupadakis, Chrisoula A. ; Wong, Alice ; Genetos, Damian C ; Chung, Dai Jung ; Murugesh, Deepa ; Anderson, Matthew J. ; Loots, Gabriela G. ; Christiansen, Blaine A ; Kapatkin, Amy ; Yellowley-genetos, Clare E. / Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair. In: Journal of Orthopaedic Research. 2012 ; Vol. 30, No. 11. pp. 1853-1859.
@article{7c94dea6d2404c41b23b3463d9af6307,
title = "Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair",
abstract = "Fracture healing involves rapid stem and progenitor cell migration, homing, and differentiation. SDF-1 (CXCL12) is considered a master regulator of CXCR4-positive stem and progenitor cell trafficking to sites of ischemic (hypoxic) injury and regulates their subsequent differentiation into mature reparative cells. In this study, we investigated the role of SDF-1/CXCR4 signaling in fracture healing where vascular disruption results in hypoxia and SDF-1 expression. Mice were injected with AMD3100, a CXCR4 antagonist, or vehicle twice daily until euthanasia with the intent to impair stem cell homing to the fracture site and/or their differentiation. Fracture healing was evaluated using micro-computed tomography, histology, quantitative PCR, and mechanical testing. AMD3100 administration resulted in a significantly reduced hyaline cartilage volume (day 14), callus volume (day 42) and mineralized bone volume (day 42) and reduced expression of genes associated with endochondral ossification including collagen Type 1 alpha 1, collagen Type 2 alpha 1, vascular endothelial growth factor, Annexin A5, nitric oxide synthase 2, and mechanistic target of rapamycin. Our data suggest that the SDF-1/CXCR4 signaling plays a central role in bone healing possibly by regulating the recruitment and/or differentiation of stem and progenitor cells.",
keywords = "adult-derived stem cells, AMD3100, CXCR4, fracture, SDF-1",
author = "Toupadakis, {Chrisoula A.} and Alice Wong and Genetos, {Damian C} and Chung, {Dai Jung} and Deepa Murugesh and Anderson, {Matthew J.} and Loots, {Gabriela G.} and Christiansen, {Blaine A} and Amy Kapatkin and Yellowley-genetos, {Clare E}",
year = "2012",
month = "11",
doi = "10.1002/jor.22145",
language = "English (US)",
volume = "30",
pages = "1853--1859",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair

AU - Toupadakis, Chrisoula A.

AU - Wong, Alice

AU - Genetos, Damian C

AU - Chung, Dai Jung

AU - Murugesh, Deepa

AU - Anderson, Matthew J.

AU - Loots, Gabriela G.

AU - Christiansen, Blaine A

AU - Kapatkin, Amy

AU - Yellowley-genetos, Clare E

PY - 2012/11

Y1 - 2012/11

N2 - Fracture healing involves rapid stem and progenitor cell migration, homing, and differentiation. SDF-1 (CXCL12) is considered a master regulator of CXCR4-positive stem and progenitor cell trafficking to sites of ischemic (hypoxic) injury and regulates their subsequent differentiation into mature reparative cells. In this study, we investigated the role of SDF-1/CXCR4 signaling in fracture healing where vascular disruption results in hypoxia and SDF-1 expression. Mice were injected with AMD3100, a CXCR4 antagonist, or vehicle twice daily until euthanasia with the intent to impair stem cell homing to the fracture site and/or their differentiation. Fracture healing was evaluated using micro-computed tomography, histology, quantitative PCR, and mechanical testing. AMD3100 administration resulted in a significantly reduced hyaline cartilage volume (day 14), callus volume (day 42) and mineralized bone volume (day 42) and reduced expression of genes associated with endochondral ossification including collagen Type 1 alpha 1, collagen Type 2 alpha 1, vascular endothelial growth factor, Annexin A5, nitric oxide synthase 2, and mechanistic target of rapamycin. Our data suggest that the SDF-1/CXCR4 signaling plays a central role in bone healing possibly by regulating the recruitment and/or differentiation of stem and progenitor cells.

AB - Fracture healing involves rapid stem and progenitor cell migration, homing, and differentiation. SDF-1 (CXCL12) is considered a master regulator of CXCR4-positive stem and progenitor cell trafficking to sites of ischemic (hypoxic) injury and regulates their subsequent differentiation into mature reparative cells. In this study, we investigated the role of SDF-1/CXCR4 signaling in fracture healing where vascular disruption results in hypoxia and SDF-1 expression. Mice were injected with AMD3100, a CXCR4 antagonist, or vehicle twice daily until euthanasia with the intent to impair stem cell homing to the fracture site and/or their differentiation. Fracture healing was evaluated using micro-computed tomography, histology, quantitative PCR, and mechanical testing. AMD3100 administration resulted in a significantly reduced hyaline cartilage volume (day 14), callus volume (day 42) and mineralized bone volume (day 42) and reduced expression of genes associated with endochondral ossification including collagen Type 1 alpha 1, collagen Type 2 alpha 1, vascular endothelial growth factor, Annexin A5, nitric oxide synthase 2, and mechanistic target of rapamycin. Our data suggest that the SDF-1/CXCR4 signaling plays a central role in bone healing possibly by regulating the recruitment and/or differentiation of stem and progenitor cells.

KW - adult-derived stem cells

KW - AMD3100

KW - CXCR4

KW - fracture

KW - SDF-1

UR - http://www.scopus.com/inward/record.url?scp=84867233412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867233412&partnerID=8YFLogxK

U2 - 10.1002/jor.22145

DO - 10.1002/jor.22145

M3 - Article

C2 - 22592891

AN - SCOPUS:84867233412

VL - 30

SP - 1853

EP - 1859

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 11

ER -